76
Participants
Start Date
October 31, 2009
Primary Completion Date
May 31, 2015
Study Completion Date
December 31, 2027
Erlotinib
150 mg taken orally once daily
Hydroxychloroquine
1000 mg taken orally once daily after erlotinib
University of Maryland, Baltimore
Stanford Cancer Institute, Stanford
Yale Cancer Center, New Haven
Massachusetts General Hospital, Boston
Collaborators (1)
Stanford University
OTHER
Yale University
OTHER
University of Maryland
OTHER
Genentech, Inc.
INDUSTRY
Massachusetts General Hospital
OTHER